Literature DB >> 24380558

Surgical margins in breast conservation.

Corrado Chiappa1, Francesca Rovera1, Adriana Dionigi Corben2, Anna Fachinetti1, Valentina De Berardinis1, Valentina Marchionini1, Stefano Rausei3, Luigi Boni3, Gianlorenzo Dionigi3, Renzo Dionigi3.   

Abstract

Breast cancer is the most common tumor affecting women worldwide. Breast-conserving therapy (BCT) followed by irradiation nowadays is the treatment of choice for early-stage disease; there is no difference in long-term survival between mastectomy and BCT combined with external radiotherapy. A positive margin is associated with increased risk of local recurrences after BCT for invasive breast cancer and ductal carcinoma in situ. The exact definition of an adequate surgical margin after breast cancer resection has long been debated among physicians and represents an area of considerable variation in clinical practice. There is a lack of standardization in the pathology methods of margin evaluation, which yields little consensus regarding what constitutes an adequate negative margin. As a consequence, patient management varies widely based on the threshold that surgeons accept for adequate margins and the subsequent need for re-excision. We analyze and discuss recent literature about this topic both from the pathological and from the surgical point of view.
Copyright © 2013 Elsevier Ltd and Surgical Associates Ltd. All rights reserved.

Entities:  

Keywords:  Breast conservative therapy; Breast surgery; Surgical margins

Mesh:

Year:  2013        PMID: 24380558     DOI: 10.1016/S1743-9191(13)60021-7

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  8 in total

1.  Visualization and tissue classification of human breast cancer images using ultrahigh-resolution OCT.

Authors:  Xinwen Yao; Yu Gan; Ernest Chang; Hanina Hibshoosh; Sheldon Feldman; Christine Hendon
Journal:  Lasers Surg Med       Date:  2017-03-06       Impact factor: 4.025

2.  Tissue-mimicking phantom materials with tunable optical properties suitable for assessment of diffuse reflectance spectroscopy during electrosurgery.

Authors:  Sara Azizian Amiri; Pieter Van Berckel; Marco Lai; Jenny Dankelman; Benno H W Hendriks
Journal:  Biomed Opt Express       Date:  2022-04-04       Impact factor: 3.562

3.  Nanoparticle Formulation of Indocyanine Green Improves Image-Guided Surgery in a Murine Model of Breast Cancer.

Authors:  Nicholas E Wojtynek; Madeline T Olson; Timothy A Bielecki; Wei An; Aaqib M Bhat; Hamid Band; Scott R Lauer; Edibaldo Silva-Lopez; Aaron M Mohs
Journal:  Mol Imaging Biol       Date:  2020-08       Impact factor: 3.488

4.  Comparative analysis of margin status in breast conservation surgery and its correlation with subsequent re-excision findings.

Authors:  K Krishnamurthy; C A Febres-Aldana; S Alghamdi; T Mesko; J Paramo; R J Poppiti
Journal:  Pathologica       Date:  2019-03

Review 5.  Image-guided tumor surgery: The emerging role of nanotechnology.

Authors:  Nicholas E Wojtynek; Aaron M Mohs
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2020-03-11

6.  Measuring Tumor Extent Based on Subtypes Using Magnetic Resonance Imaging: Radiologic-Pathologic Discordance and High Positive Margin Rates in Breast Cancer.

Authors:  Soong June Bae; Sung Gwe Ahn; Chang Ik Yoon; Ban Seok Yang; Hak Woo Lee; Eun Ju Son; Joon Jeong
Journal:  J Breast Cancer       Date:  2019-08-21       Impact factor: 3.588

7.  Pure Ductal Carcinoma In Situ of the Breast: Analysis of 270 Consecutive Patients Treated in a 9-Year Period.

Authors:  Corrado Chiappa; Alice Bonetti; Giulio Jad Jaber; Valentina De Berardinis; Veronica Bianchi; Francesca Rovera
Journal:  Cancers (Basel)       Date:  2021-01-23       Impact factor: 6.639

8.  Concept for using magnetic particle imaging for intraoperative margin analysis in breast-conserving surgery.

Authors:  Erica E Mason; Eli Mattingly; Konstantin Herb; Monika Śliwiak; Sofia Franconi; Clarissa Zimmerman Cooley; Priscilla J Slanetz; Lawrence L Wald
Journal:  Sci Rep       Date:  2021-06-29       Impact factor: 4.996

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.